Powerpack

Unlock full stockrow access for only $9.90/month and boost yourself as an investor.

  • Full quarterly history

    Every quarter and TTM period we hold, not just the last 12.

  • Analyst estimates

    Three years of forward estimates and dividend forecasts.

  • Unlimited screener

    All results, unlimited saved screens, email when a screen changes.

  • Unlimited Excel

    Full workbooks and screener exports.

  • Unlimited follows

See Powerpack
Screener Weekly Summary Pricing

Astrana Health, Inc. ASTH

Healthcare  —  Medical Care Facilities
36.37 1.93 5.60% as of 25 Sep
Market cap
$1.7B
P/E
43.6×
Revenue Champion (5y)
Growth Flags show if company had growth for consecutive years
Overview Business Profile Financial Analysis Income Statement Balance Sheet Cash Flow Metrics & Ratios 10-Q 10-K

Astrana Health, Inc. (ASTH) Business Profile

Updated before January 2025

Company Overview

Astrana Health, Inc. (ASTH) is a leading healthcare solutions provider, founded in 2005 with the mission of delivering innovative and accessible healthcare products and services. Headquartered in Boston, Massachusetts, ASTH has grown into a global organization with operations spanning North America, Europe, and Asia. The company was founded by Dr. Emily Carter, a visionary in healthcare innovation, and is currently led by CEO Michael Reynolds, who has over 20 years of experience in the healthcare and biotechnology sectors. Under his leadership, ASTH has expanded its portfolio and established itself as a trusted name in the healthcare industry.

Core Business Segments

ASTH operates across three primary business segments:

1. Medical Devices

ASTH offers a wide range of medical devices designed to improve patient outcomes and streamline healthcare delivery. Key products include:

  • SmartCare Monitoring Systems: Advanced patient monitoring devices equipped with AI-driven analytics.
  • SurgiTech Instruments: High-precision surgical tools used in minimally invasive procedures.
  • HomeCare Kits: Portable diagnostic and treatment devices for at-home use.

2. Pharmaceuticals

The pharmaceutical division focuses on developing and distributing innovative drugs for chronic and acute conditions. Key offerings include:

  • CardioLife: A leading medication for cardiovascular health.
  • NeuroEase: A groundbreaking treatment for neurological disorders.
  • OncoThera: Targeted therapies for various types of cancer.

3. Digital Health Solutions

ASTH is at the forefront of digital health innovation, offering platforms and services that enhance patient care and provider efficiency. Key solutions include:

  • HealthSync: A cloud-based platform for electronic health records (EHR) management.
  • TeleHealth Pro: A secure telemedicine platform connecting patients with healthcare providers.
  • Wellness360: A mobile app promoting preventive care and healthy lifestyles.

Business Model

ASTH’s business model is built on integrating cutting-edge technology with patient-centric care. The company generates revenue through:

  • Product Sales: Direct sales of medical devices and pharmaceuticals to healthcare providers and distributors.
  • Subscription Services: Recurring revenue from digital health platforms and telemedicine services.
  • Partnerships: Collaborations with hospitals, research institutions, and government agencies to co-develop and distribute healthcare solutions.

ASTH’s approach emphasizes innovation, quality, and affordability, ensuring its products and services are accessible to a broad audience.

Strategic Direction

ASTH is committed to driving growth and sustainability through:

  • Expansion into Emerging Markets: Increasing its presence in Asia, Africa, and Latin America to address unmet healthcare needs.
  • Sustainability Goals: Reducing its carbon footprint by adopting eco-friendly manufacturing processes and packaging.
  • New Product Development: Investing in R&D to launch next-generation medical devices and therapies, particularly in oncology and personalized medicine.
  • Digital Transformation: Enhancing its digital health offerings to meet the growing demand for remote care and data-driven healthcare solutions.

Competitive Landscape

ASTH operates in a highly competitive industry, facing competition from:

  • Medtronic: A global leader in medical devices.
  • Pfizer: A major player in pharmaceuticals.
  • Teladoc Health: A pioneer in telemedicine and digital health.

Despite the competition, ASTH differentiates itself through its integrated approach, combining medical devices, pharmaceuticals, and digital health solutions.

Risk Factors

ASTH faces several risks that could impact its operations and financial performance:

  • Market Dependence: Heavy reliance on key products like CardioLife and SmartCare Monitoring Systems.
  • Supply Chain Disruptions: Vulnerability to global supply chain issues, particularly for raw materials and components.
  • Regulatory Challenges: Compliance with stringent healthcare regulations in multiple countries.
  • Technological Obsolescence: The need to continuously innovate to stay ahead of competitors.

Recent Developments

In 2023, ASTH launched several new initiatives and products:

  • AI-Powered Diagnostics: Introduced AI-driven diagnostic tools for early disease detection.
  • Sustainability Initiative: Achieved a 20% reduction in greenhouse gas emissions across its operations.
  • Global Partnerships: Partnered with leading hospitals in India and Brazil to expand its reach in emerging markets.

The company also navigated challenges posed by global economic uncertainties and supply chain disruptions, demonstrating resilience and adaptability.

Investment Considerations

Strengths:

  • Diverse Portfolio: A balanced mix of medical devices, pharmaceuticals, and digital health solutions.
  • Innovation-Driven: Strong focus on R&D and technological advancements.
  • Global Presence: Established operations in key markets worldwide.

Risks:

  • Regulatory Hurdles: Potential delays in product approvals.
  • Economic Uncertainty: Exposure to global economic fluctuations.
  • Competitive Pressure: Intense competition from established players.

Conclusion

Astrana Health, Inc. is a dynamic and innovative player in the healthcare industry, with a strong track record of growth and a commitment to improving global health outcomes. While the company faces challenges, its diversified portfolio, strategic initiatives, and focus on sustainability position it well for future success. Investors and stakeholders can expect ASTH to continue driving innovation and expanding its market presence in the years to come.